Airathon Sprinkles, Chewable Tablets & FC Tablets
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis and chronic treatment of asthma in adults and children, and for the relief of symptoms of seasonal allergic rhinitis.
Dosage (summary)
Adults and children 15 years and older: 10 mg once daily in the evening. Children 6 to 14 years: 5 mg once daily in the evening. Children 2 to 5 years: 4 mg once daily in the evening. Chewable tablets should be chewed before swallowing.
Onset of Action / Duration
Onset of action is within 1 hour; duration of effect is 24 hours.
Special Populations
- Hepatic impairment
- Renal impairment
- Elderly patients
Pregnancy & Breastfeeding
Montelukast should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is excreted in breast milk; caution should be exercised when administered to nursing mothers.
Key Drug Interactions
- Phenobarbital may decrease montelukast levels.
- Rifampicin may decrease montelukast levels.
- Concomitant use with other medications that induce CYP450 enzymes may reduce effectiveness.
Contraindications
- Hypersensitivity to montelukast or any of the excipients.
Common side effects
- Headache
- Gastrointestinal disturbances (nausea, diarrhea)
- Fatigue
- Dizziness
- Mood changes (including agitation, aggression, anxiety, depression)
Counselling Points
- Take the medication in the evening for optimal effect.
- Do not use as a rescue medication for acute asthma attacks.
- Inform healthcare provider if experiencing mood changes or unusual behavior.
- Continue taking even if symptoms improve, unless directed otherwise by a healthcare provider.
Serious warnings
- May cause neuropsychiatric events; monitor for changes in behavior or mood.
- Use with caution in patients with a history of depression or other psychiatric disorders.
- Not a substitute for corticosteroids or other asthma medications.
Important Disclaimer
The Airathon Sprinkles, Chewable Tablets & FC Tablets professional information leaflet below is the property of Organon South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
